Target Name: MIR19B1
NCBI ID: G406980
Review Report on MIR19B1 Target / Biomarker Content of Review Report on MIR19B1 Target / Biomarker
MIR19B1
Other Name(s): hsa-miR-19b-1-5p | MiRNA19B1 | MicroRNA 19b-1 | MIRN19B1 | miRNA19B1 | hsa-mir-19b-1 | hsa-miR-19b-3p | MiR-19b-1 | MIR19B | C13orf25 | MIR17HG | MIRH1 | microRNA 19b-1 | MIRHG1 | miR-19b-1

MIR19B1: A Potential Drug Target and Biomarker for Cancer

MIR19B1 (hsa-miR-19b-1-5p), a non-coding RNA molecule, has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study.

MIR19B1 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. It is expressed in various tissues and cells throughout the body and is involved in regulating gene expression, cell growth, and apoptosis.

One of the key features of MIR19B1 is its unique 19-mer length. This is unusual for a miRNA, which typically has a length of 20 to 22 nucleotides. The longer length of MIR19B1 has been shown to give it a higher stability and stability in the body, which may contribute to its potential as a drug target.

MIR19B1 has been shown to play a role in various diseases, including cancer. For example, studies have shown that MIR19B1 is downregulated in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, MIR19B1 has been shown to be a potential biomarker for cancer, as its expression levels have been shown to be associated with the disease.

MIR19B1 has also been shown to have a positive correlation with the survival rate of cancer patients. In a study published in the journal Oncogene, researchers found that MIR19B1 was a predictor of poor prognosis in patients with pancreatic cancer. This suggests that targeting MIR19B1 may be a promising strategy for cancer treatment.

Another study published in the journal Nature Communications has shown that MIR19B1 is involved in the regulation of cellular processes, including cell growth, apoptosis, and inflammation. This suggests that MIR19B1 may be a useful target for drugs that are designed to disrupt these processes.

MIR19B1 has also been shown to have a role in the regulation of cellular immune responses. In a study published in the journal Scientific Reports, researchers found that MIR19B1 was involved in the regulation of T cell responses to cancer antigens. This suggests that targeting MIR19B1 may be a promising strategy for cancer treatment.

In conclusion, MIR19B1 is a non-coding RNA molecule that has been shown to play a role in various diseases, including cancer. Its unique structure and function make it an attractive target for researchers to study. Further studies are needed to determine the full potential of MIR19B1 as a drug target and biomarker.

Protein Name: MicroRNA 19b-1

The "MIR19B1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR19B1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR19B2 | MIR200A | MIR200B | MIR200C | MIR200CHG | MIR202 | MIR202HG | MIR203A | MIR203B | MIR204 | MIR205 | MIR2052 | MIR2052HG | MIR2053 | MIR2054 | MIR205HG | MIR206 | MIR208A | MIR208B | MIR20A | MIR20B | MIR21 | MIR210 | MIR210HG | MIR211 | MIR2110 | MIR2113 | MIR2114 | MIR2115 | MIR2116 | MIR2117 | MIR212 | MIR214 | MIR215 | MIR216A | MIR216B | MIR217 | MIR217HG | MIR218-1 | MIR218-2 | MIR219A1 | MIR219A2 | MIR219B | MIR22 | MIR221 | MIR222 | MIR223 | MIR224 | MIR2276 | MIR2277 | MIR2278 | MIR22HG | MIR2355 | MIR2392 | MIR23A | MIR23AHG | MIR23B | MIR23C | MIR24-1 | MIR24-2 | MIR2467 | MIR25 | MIR2681 | MIR2682 | MIR26A1 | MIR26A2 | MIR26B | MIR27A | MIR27B | MIR28 | MIR2861 | MIR2909 | MIR296 | MIR297 | MIR298 | MIR299 | MIR29A | MIR29B1 | MIR29B2 | MIR29B2CHG | MIR29C | MIR300 | MIR301A | MIR301B | MIR302A | MIR302B | MIR302C | MIR302D | MIR302E | MIR302F | MIR3059 | MIR3064 | MIR3065 | MIR3074 | MIR3085 | MIR30A | MIR30B | MIR30C1 | MIR30C2 | MIR30D